What is the CMHC? The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting focusing on Hypertension, Dyslipidemia, Type 2 Diabetes, Obesity,
Chronic Kidney Disease and Insulin Resistance.
The 2008 Cardiometabolic Health Congress (CMHC) gratefully acknowledges our distinguished faculty and educational supporters for contributing
to
our most successful program to date. Over 1000 U.S.-based practicing clinicians participated in our expert-level forum translating the latest clinical data in the practical strategies to prevent, delay, and manage cardiometabolic risk – with comprehensive education focusing on obesity, hypertension, dyslipidemia, atherosclerosis, and chronic kidney
disease. 2009 CMHC information will be continuously
updated on our website. Join our mailing list to be “in-the-know”.
The biggest health problem facing the world today
is from the combined impact of obesity, diabetes, and cardiovascular disease.
It is critical
that physicians and health care providers understand the predictive relationship between metabolic risk factors and cardiovascular disease and employ aggressive intervention strategies
to prevent and/or
delay disease progression.
“The CHC is unique because it brings together a wide array of experts in diabetes, insulin resistance, metabolic syndrome, and cardiovascular disease - translating the latest science into meaningful recommendations for the practicing health professional.”
- Henry Ginsberg, MD
"Cardiometabolic risk is the new paradigm that we understand patients' risk for developing cardiovascular disease and diabetes. This conference is THE place to hear all the latest information on CM risk."
- Christopher Cannon, MD
“The metabolic consequences of obesity are epidemic with resultant cardiovascular disease killing more people than cancer in the US.”
- George Bakris, MD